Location History:
- Baltimore, MD (US) (2007)
- Owings Mills, MD (US) (2009)
Company Filing History:
Years Active: 2007-2009
Title: Greg Delahanty: Innovator in Pharmaceutical Chemistry
Introduction
Greg Delahanty is a notable inventor based in Owings Mills, MD (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of water-soluble phosphonooxymethyl derivatives. With a total of 2 patents, his work has the potential to impact various pharmaceutical applications.
Latest Patents
Delahanty's latest patents focus on processes for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol. These processes are designed to create water-soluble phosphonooxymethyl ethers of hindered alcohol and phenol containing pharmaceuticals, such as camptothecin, propofol, etoposide, Vitamin E, and Cyclosporin A. The detailed methodology involves specific steps where R—OH represents an alcohol- or phenol-containing drug, and n is an integer of 1 or 2, with R being hydrogen, an alkali metal ion, or a pharmaceutically acceptable cation.
Career Highlights
Throughout his career, Greg Delahanty has worked with prominent companies in the pharmaceutical industry, including Eisai Corporation of North America and MGI GP, Inc. His expertise in the field has allowed him to contribute to innovative solutions that enhance drug solubility and efficacy.
Collaborations
Delahanty has collaborated with notable professionals in his field, including George Bonneville and Andrew J. Walz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Greg Delahanty stands out as an influential inventor in pharmaceutical chemistry, with a focus on enhancing drug formulations through innovative processes. His contributions continue to shape the landscape of pharmaceutical development.